Gerald J Gleich MD
Asthma & Allergic Conditions
Professor, Dermatology, University of Utah School of Medicine
Join to View Full Profile
50 N Medical DrSalt Lake City, UT 84132
Phone+1 801-581-2955
Fax+1 801-587-6346
Dr. Gleich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1959 - 1961
Philadelphia General HospitalInternship, Transitional Year, 1956 - 1957
University of Michigan Medical SchoolClass of 1956
Boston Children’s Hospital//Boston Medical CenterFellowship, Sports Medicine (Pediatrics)
Certifications & Licensure
MI State Medical License 1957 - Present
NY State Medical License 1961 - Present
UT State Medical License 2001 - 2026
MN State Medical License 1965 - 2016
WA State Medical License 2000 - 2003
FL State Medical License 1973 - 1998
PA State Medical License 1957 - 1976
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Allergy & Immunology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Elected Member The American Society for Clinical Investigation, 1976
Clinical Trials
- Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema Start of enrollment: 2010 Feb 01
Publications & Presentations
PubMed
- 1 citationsEpisodic angioedema associated with eosinophilia: Benralizumab-induced complete remission.Gerald J Gleich, Richard Hendershot
The Journal of Allergy and Clinical Immunology. in Practice. 2024-01-01 - 8 citationsUrine eosinophil-derived neurotoxin: A potential marker of activity in select eosinophilic disorders.Michelle A Makiya, Paneez Khoury, Fei Li Kuang, Alexis Dominique Mata, Sana Mahmood
Allergy. 2023-01-01 - 52 citationsProposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes.Peter Valent, Amy D Klion, Florence Roufosse, Dagmar Simon, Georgia Metzgeroth
Allergy. 2023-01-01
Journal Articles
- Clinical Communications Allergic Rhinitis and Asthma Induced by Boxelder Bug SensitizationGerald J Gleich, Jamie Zussman, ScienceDirect
- Dexpramipexole: A New Antieosinophil Drug?Gerald Gleich, MD, Blood
Press Mentions
Why the FDA Approved an Asthma Drug to Treat Rare Blood DisordersSeptember 26th, 2020
Mepolizumab Reduces Flares in Patients with Hypereosinophilic SyndromeNovember 19th, 2019
Grant Support
- Tmem103 In Eosinophil DevelopmentNational Institute Of Allergy And Infectious Diseases2009–2010
- Clinical Trial: Icatibant For The Treatment Of Hereditary AngioedemaNational Center For Research Resources2008
- T Cell Reactive Epitopes Of Shrimp TropomyosinNational Institute Of Allergy And Infectious Diseases2007–2008
- Standard Values Of Eosinophil-Related Parameters For Data ComparisonNational Center For Research Resources2007–2008
- The Hypereosinophilic Syndromes And MepolizumabNational Center For Research Resources2005–2008
- Icatibant For The Treatment Of Hereditary AngioedemaNational Center For Research Resources2007
- The Hypereosinophilic Syndromes And MepolizumabNational Institute Of Allergy And Infectious Diseases2004–2007
- The Hypereosinophilic Syndromes And Mepolizumab - OPEN LabelNational Center For Research Resources2005–2006
- Eosinophil Granule Proteins And Their FunctionsNational Institute Of Allergy And Infectious Diseases2002–2006
- Eosinophilia Myalgia SyndromeNational Center For Research Resources2004
- Core--Eosinophil Granule Protein LaboratoryNational Institute Of Allergy And Infectious Diseases2001–2002
- Eosinophil And Basophil Granule ProteinsNational Institute Of Allergy And Infectious Diseases2001
- Eosinophil And Basophil Granule ProteinsNational Institute Of Allergy And Infectious Diseases1997–2001
- Training Grant In Allergic DiseasesNational Institute Of Allergy And Infectious Diseases1994–2001
- Mechanisms Of Eosinophil Associated InflamationNational Institute Of Allergy And Infectious Diseases1997–2000
- Lidocaine And Sulfonylureas As Glucocorticomimetic AgentsNational Institute Of Allergy And Infectious Diseases1997–2000
- Purification &Analysis Of Primate EosinophilsNational Center For Research Resources1997
- Mechanisms Of Eosinophil-Associated InflammationNational Institute Of Allergy And Infectious Diseases1993–1996
- Functions Of EosinophilsNational Institute Of Allergy And Infectious Diseases1992–1996
- Pathogenesis Of The Eosinophilia-Myalgia SyndromeNational Institute Of Allergy And Infectious Diseases1991–1995
- Eosinophils In Human DiseaseNational Institute Of Allergy And Infectious Diseases1985–1995
- Allergic DiseasesNational Institute Of Allergy And Infectious Diseases1989–1993
- The Functions Of EosinophilsNational Institute Of Allergy And Infectious Diseases1987–1993
- Eosinophil Major Basic Protein In Human PregnancyEunice Kennedy Shriver National Institute Of Child Health &Human Development1988–1991
- Training Program In Allergic DiseasesNational Institute Of Allergy And Infectious Diseases1985–1988
- Asthma And Allergic Disease Center Program GrantNational Institute Of Allergy And Infectious Diseases1985–1987
- Immunological Sciences Study SectionCenter For Scientific Review1985–1987
- Eosinophils In Human DiseaseNational Institute Of Allergy And Infectious Diseases1986
- The Functions Of EosinophilsNational Institute Of Allergy And Infectious Diseases1985–1986
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
